Dr. Kei Hamazaki

 

Academic Degree(s)

MD, PhD

 

E-Mail

keihama@med.u-toyama.ac.jp

 

Current Position

  • Associate Professor, Department of Public Health, Faculty of Medicine, University of Toyama, Japan
  • Visiting scientist of National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan

 

Professional Experience

  • Assistant Professor, Department of Public Health, Faculty of Medicine, University of Toyama, Japan (2008-2013)
  • Researcher in Division of Clinical Application, Department of Clinical Sciences, Institute of Natural Medicine in Toyama medical and pharmaceutical University, Japan (2004-2006)
  • Physician in Mie University Hospital, in Tsu National Hospital and in Mie Prefectural General Medical Center, Japan (1996-2000)

 

Education & Training

  • School of Medicine: Mie University, Japan (1990-1996)
  • Doctorate: Toyama Medical and Pharmaceutical University, Japan (2000-2004)
  • Post-Doctoral Training: NIH, USA (2006-2008)

 

Awards

  • 2014, Mind-Body Interface International Symposium Mind-Body Interface International Symposium Overseas Travel Award
  • 2009, The 79th Annual Meeting of the Japanese Society for Hygiene: Young Investigator’s Award
  • 2008, NIH The 14th annual Fellows Award for Research Excellence (FARE) 2008 Investigator’s Award

 

Research Grants

  • Grant-in-aid for Scientific Research (C) (# 17K00849), 2017-2019
  • Grant-in-aid for Scientific Research (C) (# 25461726), 2013-2015
  • Grant-in-Aid for Young Scientists (B) (# 21790575), 2009-2012
  • The Tamura Foundation for Promotion of Science and Technology 2009-2010.
  • The Ichiro Kanehara foundation. 2011.

 

Committee & Membership

  • Director of Japan Society for Lipid Nutrition (2017-present)
  • Councilor of Japanese Society for Hygiene (2015-present)
  • A member of the International Society for the Study of Fatty Acids and Lipids

 

Selected Publication

  • Hamazaki K, et al. Fatty acid composition of the postmortem corpus callosum of patients with schizophrenia, bipolar disorder, or major depressive disorder. Eur Psychiat 2017;39:51-6
  • Hamazaki K, et al. Association of serum n-3 polyunsaturated fatty acids with psychological distress in the second and third trimesters of pregnancy: Adjunct Study of Japan Environment and Children's Study. Prostaglandins Leukot Essent Fatty Acids 2016;114:21-7
  • Hamazaki K, et al. Is vaccenic acid (18:1t n-7) associated with an increased incidence of hip fracture? An explanation for the calcium paradox. Prostaglandins Leukot Essent Fatty Acids 2016;109:2-8
  • Hamazaki K, et al. Fatty acid composition and fatty acid binding protein expression in the postmortem frontal cortex of patients with schizophrenia: A case-control study. Schizophr Res 2016;171(1-3):225-32
  • Hamazaki K, et al. Serum n-3 polyunsaturated fatty acids and psychological distress in early pregnancy: Adjunct case-control study of the Japan Environment & Children's Study. Transl Psychiatry 2016;6:e737
  • Hamazaki K, et al. Fish consumption and depressive symptoms in undergraduate students: a cross-sectional analysis. Eur Psychiat 2015;30(8):983-7
  • Hamazaki K, et al. Mead acid (20:3n-9) and n-3 polyunsaturated fatty acids are not associated with risk of posterior longitudinal ligament ossification: Results of a case-control study. Prostaglandins Leukot Essent Fatty Acids 2015; 96: 31-6
  • Hamazaki K, et al. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Psychiatry Res 2015; 227: 353-9
  • Hamazaki K, et al. The role of high-density lipoprotein cholesterol in risk for posttraumatic stress disorder: Taking a nutritional approach toward universal prevention. Eur Psychiat 2014;29:408-13
  • Hamazaki K, et al. Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder. Psychiatry Res 2013; 210:346-50